Reducing the Delay: Can a Rapid HIV Test Discriminate False Positives as Effectively as a Western Blot – the NJ Experience Eugene G. Martin, Ph.D. *, Gratian.

Slides:



Advertisements
Similar presentations
Implementing Rapid HIV Testing: Technologies, Legal and Cost Issues Vanessa Lee, MPH HIV Rapid Testing Coordinator CA Office of AIDS.
Advertisements

Post Marketing Surveillance of Oraquick Rapid HIV Testing Laura Wesolowski, PhD Gale R Burstein, MD, MPH Julia Zhu, MS Steven Ethridge, MT Division of.
Identifying HIV-2 Infections Using Differential Serological Assays HIV-1 (gp41)/HIV-2(gp36) (Select HIV or MultiSpot) by Testing HIV EIA Reactive Specimens.
Rapid HIV Testing and Its Role in Advancing HIV Prevention: 2004 Update Bernard M. Branson, M.D. Chief, Lab Determinants and Diagnostics Section Centers.
Evaluation of a Three Rapid Test Algorithm for the Diagnosis of HIV Infection at Point-of-Care Rapid Testing Facilities: Strategy 4 Data Needs. R. Boromisa.
Performance of Bio-Rad Genetic Systems HIV-1/HIV-2 Plus O EIA Followed by Multispot or OraQuick Advance in a Dual Immunoassay HIV Testing Strategy Laura.
Implementing Rapid HIV Testing in Non-traditional Sites Gratian Salaru, M.D. 1, Evan M. Cadoff, M.D. 1, Sindy M. Paul, M.D. 2, Vivian H. Shih, BA 1, Dolores.
Resolution of Discordant Confirmatory Results on POC Reactive Rapid Tests: Florida’s Pilot Project HIV Diagnostics: New Developments and Challenges Feb.
Supplemental Testing of Donors for HIV and HCV September 18, 2003 BPAC Meeting Robin Biswas, M.D. Indira Hewlett, Ph.D. FDA/CBER/OBRR/DETTD.
Rapid HIV Testing: 2005 Update Bernard M. Branson, M.D. Associate Director for Laboratory Diagnostics Division of HIV/AIDS Prevention.
Addressing the Challenges Associated with Current HIV Diagnostic Algorithms Barbara G. Werner, PhD ID Consultant, MA State Laboratory 2007 HIV Diagnostics.
Integrating Rapid HIV Testing in Emergency Care Improves HIV Detection Evan M. Cadoff, MD Robert Wood Johnson Medical School New Brunswick, NJ
Version 11Page 1 of 6 Improving Identification of Patients Infected with HIV Using Rapid Testing in the Emergency Department: A Systems-Based Approach.
Opt-Out HIV Testing in the Denver STD Clinic Kees Rietmeijer, MD, PhD Denver Public Health Department American Society for Microbiology 107 th General.
Can Sequentially Reactive EIA’s Replace HIV-1 Western Blot Testing? Robert A. Myers Ph.D.
Validation of A Proposed Testing Strategy using FDA-approved Rapid Tests Eugene Martin, Ph.D. APHA 2008 Annual Meeting San Diego, CA October 25-29, 2008.
12/6/07 v.3CDC 2007 HIV Diagnostic Conference1 Diagnosis of HIV-1 Infection in Phase I & II HIV Vaccine Trials RW Coombs 1, J Dragavon 1, B Metch 2, CJ.
CDC HIV Diagnostics Conference December 5-7, 2007 Sensitivity of OraQuick and Early Generation Enzyme Immunoassay (EIA) within a Pooled HIV Nucleic Acid.
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
Increasing Our Reach through Rapid HIV Testing Bernard M. Branson, M.D. Chief, Lab Determinants and Diagnostics Section Centers for Disease Control and.
HIV-1/HIV-2 COMBINATION SCREENING AND OUTCOMES OF FOLLOW UP William R. Oleszko, Ph.D. Associate Director, Public Health Laboratory Department of Health.
Can a second rapid HIV test discriminate false positives as effectively as a Western Blot? The NJ Experience Evan M. Cadoff, MD Robert Wood Johnson Medical.
Counseling Message: Both rapid tests we ran today were preliminary positive. It is likely that you have HIV. We always want to make absolutely sure, though,
METHODS  Based on initial OraQuick Post-Marketing Survey, the CDC made the recommendation that a discordant result should be followed-up by antibody testing.
California Department of Public Health Office of AIDS Guide for Health Department Surveillance Staff Collecting Data on the new Testing and Treatment History.
Evaluation of Commercially Available HIV Assays to Address Alternative Screening/Diagnostic Algorithms S. Michele Owen, Ph.D. Laboratory Branch Division.
Preventing HIV/AIDS There is no way to tell just by looking whether a person is infected with HIV. Because people are unaware that they are HIV-positive,
HIV Diagnosis: New Tests, New Algorithms and a New Focus Berry Bennett, MPH Retrovirology Section Chief FL Bureau of Public Health Laboratories, FDOH
APHL Survey HIV Diagnostic Testing Utilization Barbara G. Werner, PhD MA State Laboratory Institute February 28, 2005.
California Department of Public Health Office of AIDS NOTE: To view the notes section please download and save the file. In Private and other Non - Counseling.
HIV Rapid Testing Dr. Kevin Harvey National HIV/AIDS Programme Ministry of Health Jamaica.
Screening for Acute HIV-1 Infection at NYC DOHMH Public Health Laboratory William R. Oleszko, Ph.D. Associate Director, Public Health Laboratory Department.
HIV Screening and Women’s Health Health Care Education & Training, Inc. Originally developed by: Section 5: Test Options.
Incorporation of the Aptima® HIV-1 RNA Assay into Serodiagnostic and Rapid Test Confirmation Testing Algorithms to Resolve Discordant Serological Results.
HIV Testing Quality Assurance and Quality Control
Evaluation of a Proposed Testing Strategy for Laboratory-based Testing Using an HIV-1/2 Discriminatory Assay for HIV: Strategy 5 Data Needs. R. Boromisa,
Implementing Rapid HIV Testing in the United States Bernard M. Branson, M.D. Centers for Disease Control and Prevention Overview and Background.
CLINICAL TRIAL OF THE HEMA-STRIP HIV RAPID TEST USING FINGERSTICK BLOOD, WHOLE BLOOD, PLASMA, AND SERUM Niel T. Constantine 1, Dan Bigg 2, Daniel Cohen.
Performance of rapid HIV tests used singly and in combination: Moving toward a point of care diagnosis. Kevin Delaney, MPH HIV Diagnostics: New Developments.
Figure 1 A Case Series of Discordant Laboratory Results with Statewide Rapid HIV Testing in New Jersey Eugene G Martin, PhD 1, Gratian Salaru, MD 1, Sindy.
Integration of Rapid HIV Testing in Sexually Transmitted Disease Clinics In New Jersey Sindy M. Paul 1, Evan M. Cadoff 2, Eugene G. Martin 2, Maureen Wolski.
In the Footsteps of the WHO HIV Rapid Testing in the US Eugene G. Martin, Ph.D. Robert Wood Johnson Medical School New Brunswick, NJ CZECHOSLOVAK SOCIETY.
RESULTS Rapid testing started at one publicly funded counseling and testing site in New Jersey on November 1, Through December 31, 2004, 48 sites.
New HIV Test Algorithms and Revised Adult HIV Case Report Form (DCH #1355) HIV Surveillance HIV/STD/VH/TB Epidemiology Section Bureau of Epidemiology Michigan.
ORAQUICK RAPID HIV TEST Medical Center of Louisiana Cynthia Eicher, MHS MT(ASCP)SBB Denise Friloux, RN, BSN, CIC.
Results In New Jersey, the ability of satellite sites to start rapid testing is limited by the licensure process. In order to optimize the expansion of.
ABSTRACT Background: The New Jersey Department of Health and Senior Services, Division of HIV/AIDS Services (NJDHSS, DHAS)) introduced rapid HIV testing.
Rapid HIV Testing at Federally Qualified Health Care Centers in New Jersey Sindy M. Paul, M.D., M.P.H. 1, Eugene Martin, Ph.D. 2 Evan Cadoff, M.D. 2, Maureen.
Robert Wood Johnson Medical School Point of Care Testing Program Eugene G. Martin, Ph.D. Evan M. Cadoff, M.D., BLD Associate Professors of Pathology and.
HIV diagnosis (general) ImmunoassaysNAT (PCR)
CTS HIV Test Request Forms Training. Overview Introduction Introduction Explore new form Explore new form Practice Practice.
In the Footsteps of the WHO – Rapid HIV Testing in America Eugene Martin, Ph.D. *, Gratian Salaru, M.D. *, Sindy M. Paul, M.D., M.P.H.**, Evan Cadoff,
Conclusions Our quality assurance system and databases allowed us to quickly evaluate our test results in response to reports of increased numbers of false.
1 Counseling and HIV Testing HAIVN Harvard Medical School AIDS Initiatives in Vietnam.
Introduction to OraQuick Rapid HIV Testing William F. Ryan Community Health Center School Based Health Program.
HIV Testing and Diagnosis of Emergency Department Patients New Jersey, Charlotte Sadashige, MSS * ; Sindy Paul, MD, MPH * ; Eugene Martin, PhD.
Bernard M. Branson, M.D. Associate Director for Laboratory Diagnostics Divisions of HIV/AIDS Prevention National Center for HIVAIDS, Viral Hepatitis, STD,
HIV Testing in Medical Settings Mark Thrun, MD Denver Public Health
Statewide Implementation of a Rapid Testing Algorithm - New Jersey - Eugene Martin, Ph.D. UMDNJ – Robert Wood Johnson Medical School NHPC Annual Meeting.
ABSTRACT Purpose: Point-of-care rapid HIV testing is a new way to diagnose HIV disease. The New Jersey Department of Health and Senior Services Division.
If the serum specimen fails to confirm, the frozen white top tube is collected by staff from NJ HIV and sent frozen overnight to ARUP laboratories (Salt.
Incorporation of NAT into supplemental testing of HCV and HIV seroreactive donors Michael P. Busch representing Blood Systems Research Institute Blood.
CONCLUSIONS New Jersey’s Emergency Department HIV testing sites report higher seroprevalence than non-ED testing sites. Since University Hospital began.
Update Rapid HIV Testing in NJ
In the Footsteps of the WHO – Rapid HIV Testing in America
Annual HIV Coordinator’s Meeting 2011
Recreational Vehicles with “laboratory” conversion.
1985: First HIV-1 ELISA Approved by FDA
A CASE SERIES OF DISCORDANT LABORATORY RESULTS WITH RAPID HIV TESTING
Presentation transcript:

Reducing the Delay: Can a Rapid HIV Test Discriminate False Positives as Effectively as a Western Blot – the NJ Experience Eugene G. Martin, Ph.D. *, Gratian Salaru, M.D. *, Kenneth Earley * *, Phil Bruccoleri * *, Sindy M. Paul, M.D., M.P.H. * *, and Evan M. Cadoff, M.D. * UMDNJ – Robert Wood Johnson Medical School * and New Jersey Department of Health and Human Services * * CONCLUSION: A rapid, alternative confirmatory algorithm has been used to retrospectively confirm all Oraquick® HIV positive tests in New Jersey over a ten month period. A waived algorithm based upon initial Oraquick® HIV screening and confirmatory testing by Trinity Unigold™ Recombigen confirmed all Western Blot positive specimens while excluding all false positives identified by the initial Oraquick® screen. A rapid testing strategy that provides a complete answer in a single visit would allow Counseling and Testing personnel to more effectively guide HIV + patients into treatment, while avoiding the nearly 25% of HIV + clients who are lost to follow-up. Results Issues/Background Concerns about the significance of false-positive results in low-prevalence populations led the US Public Health Service to utilize a sequential, two- test algorithm (EIA followed by a Western Blot) to confirm initially reactive rapid HIV results. Confirmation of preliminary positives by Western Blot is time-consuming, complex and labor intensive. Clients often wait hours before receiving a confirmed result, experience enormous anxiety and many fail to return for follow-up. Among HIV EIA screen positive blood donors 4.8% have false positive Western Blots. 1 Prior to rapid testing approximately 35% of all patients visiting NJ Counseling and Testing Sites (CTS) for HIV testing failed to receive their results, because they failed to return for a follow-up visit. Currently, more than 97 % of tested clients receive negative results at their initial visit, but 35% of clients who need to return for HIV confirmation still fail to return and may not be referred for treatment... THE PROBLEM – The Second Visit Methods: Retrospective study using all residual specimens sent to NJ Public Health and Environmental Labs for HIV confirmatory testing. Utilizing the Western Blot serum samples available on 8 of 10 discordants, alternative rapid HIV tests were performed: ( BioRad Multispot®, MedMira Reveal®, and Trinity Uni-Gold™ ) to see whether a second, rapid HIV could effectively identify a discordant specimen. Residual specimens from 363 Western Blot confirmatory specimens were retrospectively tested with alternative rapid HIV tests: ( BioRad Multispot®, MedMira Reveal®, and Trinity Uni-Gold™ ) to see whether a second, rapid HIV could confirm a preliminary positive HIV specimen.Results IDENTIFICATION OF FALSE POSITIVES OraQuick® testing was reproducible in 7 of 8 available serum discordant specimens. Two of three alternative rapid tests ( Uni-Gold® and Reveal®) successfully identified all 8 available discordant specimens as non-reactive. The Multispot® assay correctly identified 7 of 8 samples as negative with one specimen demonstrating operator-dependent results. TOTAL TESTS 7/1/04 – 4/19/05 HIV PRELIM POSITIVE WESTERN BLOT – Discordants 15, (2.3 %)10 (3.4% of Prelim Pos. – 0.07% Overall) HIV Testing in New Jersey 1 Kleinman S, Busch MP, Hall L, et al. False-positive HIV-1 test results in a low-risk screening setting of voluntary blood donation. JAMA. 1998;280: RETURN FOR RESULTS: Of 326 Western Blot Confirmed Positive HIV results, 82 (25.2%) failed to return and were not initially notified of their HIV status. Forty seven were referred to the Notification Assistance Program (NAP). Eleven (23.4%) of those referred to the NAP were eventually located after varying periods of delay. Seventy-one (71) HIV + clients were never contacted regarding their final HIV status. PROPOSED SOLUTION: CONFIRM A RAPID HIV RESULT WITH A SECONDARY RAPID HIV TEST AT THE TIME OF THE INITIAL SCREENING THE ISSUES: Will it detect False Positives as successfully as the Western Blot? Will it confirm True Positives as effectively as the Western Blot? Oraquick Introduction Confirmatory test results 8 Western Blot negative (False Positive OraQuick) 355 Western Blot positive (True Positive OraQuick) OraSure OraQuick 7 positive 1 negative 355 positive Trinity Uni-Gold 8 negative355 positive BioRad Multispot 7 negative 1 positive 354 positive 1 QNS MedMira Reveal 8 negative340 positive 15 sample interference Follow-up of >2 months 6/6 negative Western Blot 6/6 negative viral load Trinity Uni-Gold Bio-Rad MultispotMedMira Reveal Orasure Oraquick 363 PRELIM POS 10 DISCORDANT 15,570 NEGATIVE NJ 2004 RAPID HIV TESTING